Therefore, the association of HSPA6 and SMAD9 with protein binding functions highlights their potential as key players in the pathogenesis of CRC and LUAD, providing insights into common molecular mechanisms that could be targeted for therapeutic intervention. This evidence concerns the gene SMAD9 and colorectal carcinoma.